Euglycemic DKA (euDKA) as a presentation of COVID-19.

Dass, Bhagwan; Beck, Andrew; Holmes, Cody; Morton, Glenville

Dass, Bhagwan; Beck, Andrew; Holmes, Cody; Morton, Glenville.

Afiliación

Dass B; Eglin Air Force Base Eglin AFB FL USA.
Beck A; Eglin Air Force Base Eglin AFB FL USA.
Holmes C; Eglin Air Force Base Eglin AFB FL USA.
Morton G; Eglin Air Force Base Eglin AFB FL USA.

Clin Case Rep ; 9(1): 395-398, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33362928

ABSTRACT

ABSTRACT

COVID-19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.

Palabras clave

COVID19; diabetes; diabetes mellitus; diabetes type 2; diabetic ketoacidosis; euglycemia; type I diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2021 Tipo del documento: Article